Download PDF
Thromb Haemost 1993; 70(06): 0959-0962
DOI: 10.1055/s-0038-1649707
Original Article
Coagulation
Schattauer GmbH Stuttgart

The Influence of Oral Contraceptives on the Time-Integral of Thrombin Generation (Thrombin Potential)

R C Rotteveel
1   The Department of Clinical Chemistry, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands
,
K J Roozendaal
2   The Department of Haematology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands
,
L Eijsman
3   The Department of Cardiopulmonary Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands
,
H C Hemker
4   The Department of Biochemistry, University of Limburg, Maastricht, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 03 March 1993

Accepted after revision 24 August 1993

Publication Date:
06 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

The thrombin potential (TP) has been defined as the time integral of (i.e. the area under) the thrombin generation curve. It has been shown that this parameter decreases with all types of anticoagulant treatment and increases with ATIII deficiency.

We evaluated the use of this parameter for detection of the hypercoagulative state known to accompany oral contraception.

In fresh frozen control plasma the TP could be determined with high reproducibility (n = 82, c.v. 2.9%). The TP was linearly diminished by mixing fresh frozen plasma with prothrombin deficient plasma while a high coefficient of correlation was observed (r = 0.997).

Women using oral contraceptives showed a significantly (p <0.0001) higher TP (TP = 569 nM·min, SD = 55, n = 17), compared to men or, to women not using oral contraceptives (TP = 484 nM·min, SD = 52, n = 41).

This suggests that the thrombin potential indicates the prethrombotic state known to exist in women using oral contraceptives.

 

  • References

  • 1 Hemker HC, Béguin S. How to measure the relevant effect of anticoagulant treatment of the coagulability of plasma. In: Thrombosis and its management. Poller L, Thomson JM. eds. Edinburgh: Churchill Livingstone; 1993: 03-14
    Google Scholar
  • 2 Pieters J, Willems G, Hemker HC, Lindhout T. Inhibition of factor IXa by antithrombin III/heparin during X activation. J Biol Chem 1988; 263: 15313-15318
    PubMedGoogle Scholar
  • 3 Béguin S, Mardiguian J, Lindhout T, Hemker HC. The mode of action of low molecular weight heparin preparation (PK10169) and two of its major components on thrombin generation in plasma. Thromb Haemostas 1989; 61: 30-34
    PubMedGoogle Scholar
  • 4 Hemker HC, Choay J, Béguin S. Free factor Xa is on the main pathway of thrombin generation in clotting plasma. BBA 1989; 992: 409-411
    CrossrefPubMedGoogle Scholar
  • 5 Ma Xi, Béguin S, Hemker HC. Importance of factor-IX-dependent prothrombinase formation – the Josso pathway – in clotting plasma. Hemostasis 1989; 19: 301-308
    PubMedGoogle Scholar
  • 6 Hemker HC, Willems GM, Béguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemostas 1986; 56: 09-17
    PubMedGoogle Scholar
  • 7 Von KaullaE, Droegemueller W, Aolie N, von KaullaKN. Antithrombin III depression and thrombin generation acceleration in women taking oral contraceptives. Am J Obstet Gynec 1971; 109: 868-873
    CrossrefPubMedGoogle Scholar
  • 8 Hemker HC, Wielders S, Béguin S. The thrombin potential. From Fraxiparine, second international world symposium. Recent pharmacological and clinical data New York: Schattauer; 1990: 089-101
    Google Scholar
  • 9 Ma Xi, Béguin S, Hemker HC. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients. Thromb Haemostas 1989; 62: 788-791
    PubMedGoogle Scholar
  • 10 Béguin S, Choay J, Hemker HC. The action of a synthetic pentasaccharide on thrombin generation in whole plasma. Thromb Haemostas 1989; 61: 397-401
    PubMedGoogle Scholar
  • 11 Hemker HC, Béguin S. Mode of action of unfractionated and low molecular weight heparins on the generation of thrombin in plasma. Hemostasis 1990; 20 (Suppl. 01) 81-92
    PubMedGoogle Scholar
  • 12 Béguin S, Kessels H, Dol F, Hemker HC. The consumption of antithrombin III during coagulation, its consequences for the calculation of prothrombinase activity and the standardization of heparin activity. Thromb Haemostas 1992; 68: 136-142
    PubMedGoogle Scholar
  • 13 Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310
    CrossrefPubMedGoogle Scholar
  • 14 Biggs R, MacFarlane RG. Human blood coagulation and its disorders. Oxford: Blackwell Scientific Publications; 1953
    Google Scholar
  • 15 Fagerhol MK, Abildgaard U. Immunological studies on human antithrombin III. Scand J Haemat 1970; 7: 10-17
    PubMedGoogle Scholar
  • 16 Hedlin AM. The effect of oral contraceptives estrogen on blood coagulation and fibrinolysis. Thrombos Diathes Haemorrh 1975; 33: 370-378
    PubMedGoogle Scholar
  • 17 Caine YG, Bauer KA, Barzegar S, ten CateH, Sacks FM, Walsh BW, Schiff I, Rosenberg RD. Coagulation activation following estrogen administration to postmenopausal women. Thromb Haemostas 1992; 68: 392-395
    PubMedGoogle Scholar
  • 18 Robinson GE, Burren T, Mackie IJ, Bounds W, Walshe K, Faint R, Guillebaud J, Machin SJ. Changes in hemostasis after stopping the combined contraceptive pill; implications for major surgery. BMJ 1991; 302: 269-271
    CrossrefPubMedGoogle Scholar
  • 19 Tait RC, Walker ID, Conkie JA, Islam AM, McCall F, Mitchell R, Davidson JF. Plasminogen levels in healthy volunteers – influence of age, sex smoking and oral contraceptives. Thromb Haemostas 1992; 68: 506-510
    PubMedGoogle Scholar
  • 20 Hemker HC, Wielders S, Kessels H, Béguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the endogenous thrombin potential. Thromb Haemostas. 1993. accepted for publication
    Google Scholar